Qianhai Health Holdings Ltd. (HK:0911)
:0911
Top Page
Qianhai Health Holdings Ltd.
(0911)
Select Model
Select Model
Rating:51Neutral
Price Target:
HK$0.28
▼(-1.43% Downside)
Action:ReiteratedDate:12/11/25
The overall stock score of 51 for HK:0911 reflects a cautious outlook, driven primarily by mixed financial performance (score: 55, weight: 0.5) with strong balance sheet stability but significant revenue declines and weak profitability. Technical analysis (score: 50, weight: 0.3) indicates neutral momentum with no clear trend, while valuation (score: 40, weight: 0.2) is a concern due to negative earnings. Financial stability is the key strength, but profitability challenges remain the dominant risk.
Positive Factors
Balance Sheet Health
A strong equity position and low leverage risk provide financial stability, allowing the company to withstand economic fluctuations and invest in growth opportunities.
Negative Factors
Revenue Volatility
Significant revenue fluctuations indicate instability in demand or market conditions, which can challenge consistent growth and strategic planning.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Health
A strong equity position and low leverage risk provide financial stability, allowing the company to withstand economic fluctuations and invest in growth opportunities.
Read all positive factors
Qianhai Health Holdings Ltd. (0911) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$44.90M
Dividend YieldN/A
Average Volume (3M)199.38K
Price to Earnings (P/E)7.8
Beta (1Y)0.16
Revenue Growth-40.37%
EPS Growth-112.64%
CountryHK
Employees14
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)<0.01
Shares Outstanding169,445,000
10 Day Avg. Volume241,207
30 Day Avg. Volume199,376
Financial Highlights & Ratios
PEG Ratio-0.30
Price to Book (P/B)0.13
Price to Sales (P/S)0.09
P/FCF Ratio11.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Qianhai Health Holdings Ltd. Business Overview & Revenue Model
Company Description
Qianhai Health Holdings Limited, an investment holding company, engages in the sale of health products and electronic component products in Hong Kong. The company operates through Health-Care Products and Electronic Component Products segments. It...
How the Company Makes Money
Qianhai Health Holdings generates revenue through multiple streams, primarily from the sale of its health supplements and traditional Chinese medicine products. The company capitalizes on the growing consumer preference for health and wellness pro...
Qianhai Health Holdings Ltd. Financial Statement Overview
Summary
Income Statement
25
Negative
Balance Sheet
75
Positive
Cash Flow
60
Neutral
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 383.16M | 519.70M | 961.29M | 1.96B | 283.40M | 760.72M |
| Gross Profit | -6.15M | 29.67M | -35.60M | 76.48M | 16.04M | 45.13M |
| EBITDA | 1.78M | 15.64M | -50.23M | -231.24M | 2.06M | 5.63M |
| Net Income | -11.85M | 1.31M | -52.70M | -233.70M | -888.00K | -804.00K |
Balance Sheet | ||||||
| Total Assets | 392.38M | 407.31M | 478.12M | 534.43M | 738.63M | 735.47M |
| Cash, Cash Equivalents and Short-Term Investments | 27.43M | 23.51M | 19.52M | 1.64M | 2.47M | 16.36M |
| Total Debt | 733.00K | 1.03M | 487.00K | 1.19M | 7.83M | 24.07M |
| Total Liabilities | 2.32M | 21.74M | 94.00M | 97.73M | 68.09M | 62.28M |
| Stockholders Equity | 390.06M | 385.57M | 384.11M | 436.70M | 670.53M | 673.19M |
Cash Flow | ||||||
| Free Cash Flow | 10.48M | 4.19M | 857.00K | -5.26M | -44.19M | -70.90M |
| Operating Cash Flow | 10.48M | 4.20M | 857.00K | -5.26M | -44.18M | -70.89M |
| Investing Cash Flow | 11.00K | 246.00K | 17.77M | 12.34M | 46.84M | 122.43M |
| Financing Cash Flow | -340.00K | -712.00K | -743.00K | -7.91M | -16.56M | -55.19M |
Qianhai Health Holdings Ltd. Technical Analysis
Negative
0.28
Price Trends
0.28
Negative
0.28
Negative
0.27
Negative
Market Momentum
>-0.01
Positive
40.47
Neutral
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0911, the sentiment is Negative. The current price of 0.28 is above the 20-day moving average (MA) of 0.28, above the 50-day MA of 0.28, and above the 200-day MA of 0.27, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 40.47 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0911.
Qianhai Health Holdings Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
54 Neutral | HK$211.65M | -0.15 | -30.35% | ― | -11.89% | -290.48% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | HK$44.90M | 7.84 | -3.06% | ― | -40.37% | -112.64% | |
49 Neutral | HK$926.38M | -2.84 | -48.86% | ― | -43.46% | -96.48% | |
48 Neutral | HK$177.84M | -38.07 | -8.95% | ― | 2.54% | 33.33% | |
44 Neutral | HK$167.36M | -0.14 | -43.61% | ― | 6.55% | -475.22% | |
42 Neutral | HK$163.16M | -4.22 | -30.35% | ― | -17.32% | 55.74% |
* Healthcare Sector Average
HK:0911
Qianhai Health Holdings Ltd.
0.27
0.04
15.22%
HK:0858
Extrawell Pharmaceutical Holdings Limited
0.08
0.04
97.62%
HK:1312
Kontafarma China Holdings Ltd
0.03
<0.01
30.43%
HK:1498
PuraPharm Corp. Ltd.
0.31
-0.20
-39.00%
HK:1652
Fusen Pharmaceutical Co., Ltd.
1.26
1.02
425.00%
HK:8622
Huakang Biomedical Holdings Company Limited
0.35
0.06
23.21%
Qianhai Health Holdings Ltd. Corporate Events
Qianhai Health Books HK$60.4 Million Onerous Contract Provision on Electronics Products
Dec 19, 2025
Qianhai Health Holdings Limited has issued a supplemental announcement to its 2024 annual results and annual report, disclosing additional details on a HK$60.4 million provision for onerous contracts linked to its electronics-related operations. T...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.